Multiple endocrine neoplasia type 1 (MEN1), a rare tumor syndrome that is inherited in an
autosomal dominant pattern, is continuing to raise great interest for endocrinology …

Simple Summary Pancreatic neuroendocrine tumors (pNETs) are rare, indolent cancers
whose causation is only partly understood. An increasing number of studies have uncovered …

Pancreatic neuroendocrine tumors (pNETs) are a rare group of cancers accounting for about
1–2% of all pancreatic neoplasms. About 10% of pNETs arise within endocrine tumor …

Von Hippel–Lindau disease (VHL) is a multineoplasm inherited disease manifesting with
hemangioblastoma of the central nervous system and retina, adrenal pheochromocytoma …

Here we report the DNA methylation profile of 84 sporadic pancreatic neuroendocrine
tumors (PanNETs) with associated clinical and genomic information. We identified three …

Simple Summary ATRX is one of the most frequently mutated tumor suppressor genes in
human cancers. ATRX protein is a chromatin remodeler and transcriptional regulator that is …

Neuroendocrine tumors, or NETs, are cancer originating in neuroendocrine cells. They are
mostly found in the gastrointestinal tract or lungs. Functional NETs are characterized by …

Metastatic duodenopancreatic neuro-endocrine tumors (dpNETs) are the most important
disease-related cause of death in patients with multiple endocrine neoplasia type 1 (MEN1) …

Pancreatic neuroendocrine neoplasms (pNENs) are rare cancers with broad challenges for
their management. The main clinical obstacles are the high rate of patients diagnosed at …

RNA-binding proteins (RBPs) are critical players in the post-transcriptional regulation of
gene expression and are associated with each event in RNA metabolism. The term 'RNA …